Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP)

About the company

Oramed Pharmaceuticals, Inc. engages in the provision of oral delivery solutions for drugs delivered via injection. It focuses in the research and development of pharmaceutical solutions, including an oral insulin capsule to be used for the treatment of individuals with diabetes, and the use of orally ingestible capsules or pills for delivery of other polypeptides. The company was founded by Nadav Kidron and Miriam Kidron on April 12, 2002 and is headquartered in New York, NY.

Sector

Health Technology

Industry

Pharmaceuticals: Other

Employees

13

CEO

Nadav Kidron

Exchange

NASDAQ

Website

http://www.oramed.com

$3.00M

Total Revenue

13

Employees

$61.02M

Market Capitalization

-4.77

Price/Earning ratio

Stock price

Gross Margin (in %)

Total gross margin

$3M

Operating Margin (in %)

Total operating margin

$-14M

Net Margin (in %)

Total net margin

$-14M

Dividend Yield (in %)

Dividend per share

$0

Industry peers

Name Ticker Market capitalization (in USD Million) Revenues (in USD Million) Price/Book Price/Earning Net margin (in %)
Horizon Therapeutics Plc HZNP 12180.00 1376.00 5.19 19.21 43.06
Catalent, Inc. CTLT 10896.37 2872.00 5.47 104.47 3.63
Perrigo Co. Plc PRGO 7433.62 4837.00 1.27 50.71 3.02
Bausch Health Cos., Inc. BHC 6195.15 8597.00 8.65 -3.27 -21.96
Jazz Pharmaceuticals Plc JAZZ 6129.78 2188.00 2.12 22.40 12.81
United Therapeutics Corp. UTHR 5027.56 1443.00 1.75 9.70 36.59
MyoKardia, Inc. MYOK 4325.84 34.00 12.57 -13.95 -201.73
Axsome Therapeutics, Inc. AXSM 3004.40 None 20.39 -33.40 None
Pacira Biosciences, Inc. PCRX 2415.84 435.00 6.48 -5752.00 -0.02
SAGE Therapeutics, Inc. SAGE 2295.80 9.00 2.70 -3.55 -413.06
ArQule, Inc. ARQL 2240.00 5.00 15.75 -55.56 -808.06
Corcept Therapeutics, Inc. CORT 2043.50 335.00 4.69 19.25 31.64
Prestige Consumer Healthcare, Inc. PBH 1816.11 963.00 1.53 12.81 14.77
Revolution Medicines, Inc. RVMD 1631.94 48.00 4.24 -23.05 -146.29
Madrigal Pharmaceuticals, Inc. MDGL 1615.50 0.00 4.31 -15.81 -624.74
Ironwood Pharmaceuticals, Inc. IRWD 1548.02 440.00 -21.91 18.26 19.14
Innoviva, Inc. INVA 1534.54 285.00 3.63 7.94 66.41
Intercept Pharmaceuticals, Inc. ICPT 1409.60 272.00 -41.95 -4.11 -127.53
Portola Pharmaceuticals, Inc. PTLA 1329.78 121.00 19.53 -4.77 -232.73
Supernus Pharmaceuticals, Inc. SUPN 1274.94 402.00 2.02 10.93 28.90
Zogenix, Inc. ZGNX 1251.45 5.00 3.42 -2.94 -241.62
Theravance Biopharma, Inc. TBPH 1220.94 88.00 -8.57 -4.95 -280.80
Revance Therapeutics, Inc. RVNC 1190.98 0.00 4.70 -6.38 41.82
Amphastar Pharmaceuticals, Inc. AMPH 1020.18 327.00 2.55 20.02 15.90
Endo International Plc ENDP 766.08 3014.00 -1.05 -2.73 -9.09
BellRing Brands, Inc. BRBR 745.68 954.00 -0.40 5.66 13.98
Assembly Biosciences, Inc. ASMB 680.34 16.00 3.05 -6.84 -601.75
Eagle Pharmaceuticals, Inc. EGRX 648.90 192.00 3.49 257.50 1.29
Aerie Pharmaceuticals, Inc. AERI 616.86 79.00 4.89 -3.05 -252.92
Collegium Pharmaceutical, Inc. COLL 582.76 299.00 4.17 -45.11 -4.21
Catalyst Pharmaceuticals, Inc. CPRX 536.07 119.00 5.22 12.22 36.09
Anika Therapeutics, Inc. ANIK 486.78 125.00 1.68 17.56 22.73
Intersect ENT, Inc. XENT 445.76 102.00 4.21 -8.93 -48.61
BioDelivery Sciences International, Inc. BDSI 392.84 130.00 5.62 -53.37 -5.01
ANI Pharmaceuticals, Inc. ANIP 367.56 203.00 1.88 -235.62 -0.67
Albireo Pharma, Inc. ALBO 329.29 11.00 3.35 -4.31 -730.55
MEI Pharma, Inc. MEIP 285.52 5.00 4.91 -7.32 -539.48
Mallinckrodt Plc MNK 199.08 3037.00 0.11 -0.17 -39.56
Agile Therapeutics, Inc. AGRX 161.66 None 2.63 -7.83 None
Marinus Pharmaceuticals, Inc. MRNS 151.20 0.00 5.85 -2.24 None
Cerecor, Inc. CERC 117.76 7.00 7.53 -5.22 -429.22
Ampio Pharmaceuticals, Inc. AMPE 98.38 1.00 68.80 -5.29 None
Evoke Pharma, Inc. EVOK 85.92 None 29.83 -12.79 None
AcelRx Pharmaceuticals, Inc. ACRX 85.60 2.00 -1.57 -1.53 -644.25
CTI BioPharma Corp. CTIC 83.78 3.00 3.74 -2.03 -111.83
Zynerba Pharmaceuticals, Inc. ZYNE 79.12 0.00 1.30 -2.21 -699.94
Aclaris Therapeutics, Inc. ACRS 73.80 4.00 1.29 -0.54 None
Adamas Pharmaceuticals, Inc. ADMS 70.84 57.00 -4.52 -0.76 -160.44
Oramed Pharmaceuticals, Inc. ORMP 61.02 3.00 4.91 -4.77 -464.15
Cassava Sciences, Inc. SAVA 58.14 41.00 3.06 -12.75 76.71
SCYNEXIS, Inc. SCYX 48.69 0.00 10.23 -1.26 -30.84
Cumberland Pharmaceuticals, Inc. CPIX 48.00 47.00 0.98 -10.67 -9.59
Natural Alternatives International, Inc. NAII 47.67 114.00 0.65 -12.61 -3.19
IsoRay, Inc. ISR 46.90 9.00 8.75 -14.00 -36.08
Lipocine, Inc. LPCN 39.90 0.00 9.50 -2.66 None
Acasti Pharma, Inc. ACST 35.84 827.00 2.33 -0.58 -7.45
Neos Therapeutics, Inc. NEOS 34.50 65.00 -2.65 -1.97 -26.74
PLx Pharma, Inc. PLXP 25.88 0.00 -2.48 -2.74 119.04
CytRx Corp. CYTR 22.11 0.00 1.60 -3.19 408.46
EyeGate Pharmaceuticals, Inc. EYEG 20.80 3.00 2.59 -1.76 -264.21
Regulus Therapeutics, Inc. RGLS 17.49 0.00 1.54 -0.82 -272.13
Tetraphase Pharmaceuticals, Inc. TTPH 12.40 8.00 0.66 -0.15 -798.18
Intec Pharma Ltd. NTEC 10.18 None 1.31 -0.24 None
Hepion Pharmaceuticals, Inc. HEPA 7.38 None 2.31 -0.62 None
Sonoma Pharmaceuticals, Inc. SNOA 6.35 19.00 1.01 -2.04 -25.58
VIVUS, Inc. VVUS 6.27 73.00 -0.14 -0.21 -39.28
KemPharm, Inc. KMPH 6.02 15.00 -0.17 -0.35 -120.48
Tonix Pharmaceuticals Holding Corp. TNXP 4.62 None 1.16 -0.10 None
Ritter Pharmaceuticals, Inc. RTTR 0.45 None 0.17 -0.03 None

Latest insider transactions

Date Role Name Transaction Quantity Quantity Owned After

Oramed: Fiscal 3Q Earnings Snapshot

1d ago, source: YAHOO!

(ORMP) on Tuesday reported a loss of $2.3 million in its fiscal third quarter. The New York-based company said it had a loss of 10 cents per share. The drug maker posted revenue of $681,000 in the ...

Does Earnings Surprise History Hold Any Clue for Oramed Pharmaceuticals, Inc. (NASDAQ:ORMP)

2d ago, source: Stock Market Daily

Oramed Pharmaceuticals, Inc. announce their quarterly, annual earnings. See the latest EPS estimates. Listen to the ...

Insulin in Pill Form Would Be a Bonanza for Oramed

1d ago, source: YAHOO!

Pharmaceutical companies have poured millions--maybe billions--of dollars into research aimed at finding a way to deliver insulin to patients by mouth. More than 500 million people worldwide have ...

BRIEF-Oramed Pharmaceuticals Reports Quarterly Loss Per Share Of $0.10

2d ago, source: Reuters

ORAMED PHARMACEUTICALS INC QUARTERLY REVENUES $681,000 VERSUS $682,000 Source text: [bit.ly/3iHdMF9] Further company coverage: (Reuters.Briefs@thomsonreuters.com) Our Standards:The Thomson Reuters ...

Oramed Pharmaceuticals Inc.

8d ago, source: Barron's

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

Oramed Pharmaceuticals EPS beats by $0.10, beats on revenue

1d ago, source: Seeking Alpha

Oramed Pharmaceuticals (NASDAQ:ORMP): Q3 GAAP EPS of -$0.10 beats by $0.10. Revenue of $0.68M (flat Y/Y) beats by $0.17M. Press Release ...

Oramed Announces Positive Initial Clinical Trial Results for Treatment of NASH With Oral Insulin

25d ago, source: MarketWatch

NEW YORK, June 15, 2020 /PRNewswire via COMTEX/ -- NEW YORK, June 15, 2020 /PRNewswire/ -- Oramed Pharmaceuticals Inc. (Nasdaq: ORMP) (TASE: ORMP) (www.oramed.com), a ...



Portfolio items

Follow companies to create your optimal portfolio.
or
Refresh this page to see your newly added stocks.